74 research outputs found
The global burden of adolescent and young adult cancer in 2019 : a systematic analysis for the Global Burden of Disease Study 2019
Background In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15-39 years to define adolescents and young adults. Findings There were 1.19 million (95% UI 1.11-1.28) incident cancer cases and 396 000 (370 000-425 000) deaths due to cancer among people aged 15-39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59.6 [54.5-65.7] per 100 000 person-years) and high-middle SDI countries (53.2 [48.8-57.9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14.2 [12.9-15.6] per 100 000 person-years) and middle SDI (13.6 [12.6-14.8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23.5 million (21.9-25.2) DALYs to the global burden of disease, of which 2.7% (1.9-3.6) came from YLDs and 97.3% (96.4-98.1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe
The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019
Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and over the past decade. Estimates are also provided by quintiles of the SDI, a composite measure of educational attainment, income per capita, and total fertility rate for those younger than 25 years. Estimates include 95% uncertainty intervals (UIs). In 2019, there were an estimated 23.6 million (95% UI, 22.2-24.9 million) new cancer cases (17.2 million when excluding nonmelanoma skin cancer) and 10.0 million (95% UI, 9.36-10.6 million) cancer deaths globally, with an estimated 250 million (235-264 million) DALYs due to cancer. Since 2010, these represented a 26.3% (95% UI, 20.3%-32.3%) increase in new cases, a 20.9% (95% UI, 14.2%-27.6%) increase in deaths, and a 16.0% (95% UI, 9.3%-22.8%) increase in DALYs. Among 22 groups of diseases and injuries in the GBD 2019 study, cancer was second only to cardiovascular diseases for the number of deaths, years of life lost, and DALYs globally in 2019. Cancer burden differed across SDI quintiles. The proportion of years lived with disability that contributed to DALYs increased with SDI, ranging from 1.4% (1.1%-1.8%) in the low SDI quintile to 5.7% (4.2%-7.1%) in the high SDI quintile. While the high SDI quintile had the highest number of new cases in 2019, the middle SDI quintile had the highest number of cancer deaths and DALYs. From 2010 to 2019, the largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles. The results of this systematic analysis suggest that the global burden of cancer is substantial and growing, with burden differing by SDI. These results provide comprehensive and comparable estimates that can potentially inform efforts toward equitable cancer control around the world.Funding/Support: The Institute for Health Metrics and Evaluation received funding from the Bill & Melinda Gates Foundation and the American Lebanese Syrian Associated Charities. Dr Aljunid acknowledges the Department of Health Policy and Management of Kuwait University and the International Centre for Casemix and Clinical Coding, National University of Malaysia for the approval and support to participate in this research project. Dr Bhaskar acknowledges institutional support from the NSW Ministry of Health and NSW Health Pathology. Dr Bärnighausen was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, which is funded by the German Federal Ministry of Education and Research. Dr Braithwaite acknowledges funding from the National Institutes of Health/ National Cancer Institute. Dr Conde acknowledges financial support from the European Research Council ERC Starting Grant agreement No 848325. Dr Costa acknowledges her grant (SFRH/BHD/110001/2015), received by Portuguese national funds through Fundação para a Ciência e Tecnologia, IP under the Norma Transitória grant DL57/2016/CP1334/CT0006. Dr Ghith acknowledges support from a grant from Novo Nordisk Foundation (NNF16OC0021856). Dr Glasbey is supported by a National Institute of Health Research Doctoral Research Fellowship. Dr Vivek Kumar Gupta acknowledges funding support from National Health and Medical Research Council Australia. Dr Haque thanks Jazan University, Saudi Arabia for providing access to the Saudi Digital Library for this research study. Drs Herteliu, Pana, and Ausloos are partially supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNDS-UEFISCDI, project number PN-III-P4-ID-PCCF-2016-0084. Dr Hugo received support from the Higher Education Improvement Coordination of the Brazilian Ministry of Education for a sabbatical period at the Institute for Health Metrics and Evaluation, between September 2019 and August 2020. Dr Sheikh Mohammed Shariful Islam acknowledges funding by a National Heart Foundation of Australia Fellowship and National Health and Medical Research Council Emerging Leadership Fellowship. Dr Jakovljevic acknowledges support through grant OI 175014 of the Ministry of Education Science and Technological Development of the Republic of Serbia. Dr Katikireddi acknowledges funding from a NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2), and the Scottish Government Chief Scientist Office (SPHSU17). Dr Md Nuruzzaman Khan acknowledges the support of Jatiya Kabi Kazi Nazrul Islam University, Bangladesh. Dr Yun Jin Kim was supported by the Research Management Centre, Xiamen University Malaysia (XMUMRF/2020-C6/ITCM/0004). Dr Koulmane Laxminarayana acknowledges institutional support from Manipal Academy of Higher Education. Dr Landires is a member of the Sistema Nacional de Investigación, which is supported by Panama’s SecretarÃa Nacional de Ciencia, TecnologÃa e Innovación. Dr Loureiro was supported by national funds through Fundação para a Ciência e Tecnologia under the Scientific Employment Stimulus–Institutional Call (CEECINST/00049/2018). Dr Molokhia is supported by the National Institute for Health Research Biomedical Research Center at Guy’s and St Thomas’ National Health Service Foundation Trust and King’s College London. Dr Moosavi appreciates NIGEB's support. Dr Pati acknowledges support from the SIAN Institute, Association for Biodiversity Conservation & Research. Dr Rakovac acknowledges a grant from the government of the Russian Federation in the context of World Health Organization Noncommunicable Diseases Office. Dr Samy was supported by a fellowship from the Egyptian Fulbright Mission Program. Dr Sheikh acknowledges support from Health Data Research UK. Drs Adithi Shetty and Unnikrishnan acknowledge support given by Kasturba Medical College, Mangalore, Manipal Academy of Higher Education. Dr Pavanchand H. Shetty acknowledges Manipal Academy of Higher Education for their research support. Dr Diego Augusto Santos Silva was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de NÃvel Superior - Brasil Finance Code 001 and is supported in part by CNPq (302028/2018-8). Dr Zhu acknowledges the Cancer Prevention and Research Institute of Texas grant RP210042
L'industrie de la pince à Montecheroux
L'industrie de la pince échenoumontaine, après moult vicissitudes, qui se prolongent encore — marché en récession, concurrence étrangère, outil de production inadapté — revit peu à peu. Cette situation fut pourtant tout autre, en effet, la pince maillée, produit emblématique de ce lieu, connut longtemps un essor extraordinaire. Exportée aux quatre coins du globe, elle fut l'ambassadrice du savoir-faire local. Un savoir-faire à propos duquel on s'interroge aujourd'hui. Celui-ci a été longtemps..
Physical and photoelectrochemical properties of spherical nanoparticles of α-AgBiS 2
International audienceWe have investigated the physical and photo electrochemical properties of α-AgBiS2 (schapbachite), synthesized from Bi2S3 and Ag2S in evacuated Pyrex ampoule at 550 °C. The precursors are prepared by precipitation from nitrates in ethylene glycol using thiourea as complexing agent and sulfide source. AgBiS2 crystallizes in a rock salt structure (Fm-3m). The transmission electron micrograph shows spherical nanoparticles with an average size of ~ 30 nm, a value very close to that obtained from the Williamson-Hall plot of the XRD powder pattern (33.06±1.28 nm). HRTEM gives inter reticular distance of 0.33 nm, a value in excellent agreement with that of the SAED analysis (d111=0.3276 nm). The diffuse reflectance spectrum indicates a direct optical transition of 0.89 eV. The thermal variation of the electrical conductivity is characteristic of semiconducting behavior with activation energy of 0.20 eV, electron mobility (µ300K) of 2.43 × 10−4 cm2 V−1 s−1 and an effective mass of 2.88 mo. The intensity-potential J(V) curve in alkaline medium (pH 10.2) shows a good electrochemical stability. The dark capacitance (C−2-V) exhibits a linear behavior, characteristic of n-type conduction (dC−2/dE>0), from which a flat band potential of 0.33 VSCE and an electrons density of 2.57 × 1021 cm−3 are determined. The valence band derives from S2−: 3p states while the conduction band is made up mainly of Ag+: 5 s orbital. The electrochemical impedance spectroscopy (EIS), measured in the dark and under illumination over the frequency range (10−3−105 Hz), indicates the contribution of both the bulk and grain boundaries.Graphical abstrac
Improved activity of SnO for the photocatalytic oxygen evolution
SnO prepared by soft chemistry exhibits a black color and semiconducting properties. The X-ray diffraction indicates a tetragonal symmetry (SG: P4/nmm) with nano crystallites of an average size of 85 nm. The forbidden band, determined from the diffuse reflectance is found to be 1.46 eV. The electrical conductivity occurs by polaron hopping and follows an Arrhenius type law with activation energy of 0.21 eV, the change in the slope at 526 K is attributed to the oxidation to SnO2. The photo-electrochemical study shows n type conduction with a flat band potential of −0.45 V, close to the photocurrent onset potential (−0.40 V). The electrochemical impedance spectroscopy shows the bulk contribution of SnO (Rb = 1.7 kΩ cm2) and decreases down to 1.89 kΩ cm2 under illumination. The photocatalytic properties have been evaluated for the first time for to the oxygen evolution. The valence band, deriving from Sn2+: 5p orbital with a potential (−0.80 VSCE/5.55 eV), is suitably positioned with respect to O2/H2O level (∼0.6 VSCE), leading to water oxidation under visible light. The best performance occurs at pH ∼ 7 with an oxygen liberation rate of 23 µmol mL h−1 (mg catalyst)−1 and a quantum efficiency of 1.2%. An improvement of ∼13% is observed on the system SnO/clay
Test result analysis with respect to formal specifications
There are two aspects to testing: (1) the selection of appropriate test inputs and (2) the analysis of the observed interactions of the implementation under test (IUT) in order to determine whether they conform to the IUT's specification. The paper considers the second aspect with particular attention to the testing o
A new hetero-junction p-CuO/n-ZnO for the removal of amoxicillin by photocatalysis under solar irradiation
International audienceThe main objective of this study was to evaluate the efficiency of a new hetero-junction p-CuO/n-ZnO assisted photo-catalytic process for the degradation of amoxicillin (AMX). The catalysts is synthesized by chemical route and characterized by X-ray diffraction, scanning electron microscopy (SEM), thermal analysis, BET specific surface area and photo-electrochemistry. The initial AMX concentration, photo-catalyst nature, catalyst dose and initial pH of the solution were optimized in order to evaluate the mineralization extent. AMX (50 mg/l) was almost entirely removed after 4 h of exposure to solar irradiation at pH similar to 11, by using the hetero-junction ZnO/CuO (50:50 wt%). The final AMX concentration was determined by high performance liquid chromatography (HPLC) equipped with a photodiode array detector. The analysis of NO(3)(-)and SO42- released by the degradation reaction were quantified by ionic chromatography and the total organic carbon (TOC) indicated a high mineralization degree of AMX. Kinetic analysis suggested that the AMX degradation obeys to a pseudo-first-order with a rate constant of 9.95 x 10(-3) min(-1). Finally, the application of this method was extended to real effluents. (C) 2016 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved
Photo-electrochemical properties of p-type AgCoO2 prepared by low temperature method
WOS:000454537700024AgCoO2 prepared by co-precipitation at low temperature (similar to 80 degrees C) is characterized by physical and photo-electrochemical techniques. The X-ray diffraction shows broad peaks with a particle size of similar to 20 nm and a specific surface area of similar to 28 m(2) g(-1). The forbidden band (1.33 eV) is due to Ag+ : d -> d transition, further transition at 4.50 eV is assigned to the charge transfer. The transport properties, measured up to 650 K, indicate intrinsic conductivity: sigma = sigma(o) exp{- 0.24 eV/kT (Omega-cm)(-1)}, supporting a phonon assisted conduction mechanism. An exchange current density of 1.27 mA cm(-2) in Na2SO4 (0.1 M) solution is consistent with the electrochemical stability up to 0.8 V-SCE. The capacitance measurement (C-2 - E) indicates p type conduction, with a flat band potential (E-fb) of 0.26 V-SCE and a holes density (N-A) of 7.38 x 10(19) cm(-3) due to the oxygen insertion in the layered lattice. The electrochemical impedance spectroscopy (EIS) data, recorded in the range (1 mHz - Hz), reveals a predominant bulk contribution with a low depletion angle of 3 degrees and a pseudo capacitive behavior. As application, AgCoO2 is tested for the hydrogen production upon visible illumination owing to the potential of its conduction band (-0.83 V-SCE), less cathodic than that of H2O/H-2 (similar to -0.5 V-SCE). H-2 evolution rate of 79 mu mol g(-1) min(-1) is determined at neutral pH with a quantum yield of 1.92% in presence of NO2 as hole scavenger; no Ag deposition was observed after photocatalysis.Faculty of Chemistry (USTHB) Algiers [E00220140035]The work was supported by the Faculty of Chemistry (USTHB) Algiers under the Project No E00220140035
- …